Cassava sciences inc (SAVA)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Current assets:
Cash and cash equivalents

25,600

23,081

17,804

18,534

19,125

19,807

20,444

9,608

10,734

10,479

11,916

14,067

17,264

16,615

21,214

24,626

26,614

31,299

33,993

36,352

37,249

40,590

42,052

44,575

45,852

48,588

49,727

51,545

51,591

49,355

88,240

79,020

73,779

73,144

71,709

62,830

4,798

Marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

2,099

550

-

1,500

-

900

950

1,999

-

1,100

250

1,250

1,250

1,300

1,300

2,800

6,899

4,289

14,922

22,117

24,987

27,651

38,211

86,428

Receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

231

908

7,114

Other current assets

277

268

385

49

140

233

276

91

155

184

288

12

126

356

456

115

299

392

520

200

119

239

358

482

141

265

389

3

127

253

378

95

475

358

493

15

144

Total current assets

25,877

23,349

18,189

18,583

19,265

20,040

20,720

9,699

10,889

10,663

12,204

14,079

17,390

19,070

22,220

24,741

28,413

31,691

35,413

37,502

39,367

40,829

43,510

45,307

47,243

50,103

51,416

52,848

54,518

56,507

92,907

94,037

96,371

98,489

100,084

101,964

98,484

Operating lease right-of-use assets

67

90

113

135

158

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment, net

33

47

61

75

88

87

104

122

139

156

173

190

214

232

250

187

201

215

228

242

256

65

69

72

76

-

-

-

-

-

-

52

87

122

157

192

285

Other assets

-

-

12

12

12

12

12

12

30

12

-

-

-

-

12

12

12

12

12

12

12

12

12

12

-

-

340

352

352

352

352

351

352

352

351

437

426

Total assets

25,977

23,486

18,375

18,805

19,523

20,139

20,836

9,833

11,058

10,831

12,377

14,269

17,604

19,302

22,482

24,940

28,626

31,918

35,653

37,756

39,635

40,906

43,591

45,391

47,319

50,103

51,756

53,200

54,870

56,859

93,259

94,440

96,810

98,963

100,592

102,593

99,195

Current liabilities:
Accounts payable

608

453

340

594

495

294

549

962

421

424

712

658

573

303

1,083

378

1,043

1,034

898

465

255

173

822

360

428

445

531

435

366

361

507

501

502

464

556

604

1,107

Accrued development expense

387

777

415

179

243

156

-

-

18

399

-

32

8

27

744

641

818

894

642

-

-

25

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued development expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

448

207

-

337

332

301

641

742

572

382

929

793

605

419

914

754

576

258

Deferred program fee revenue - current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,832

7,832

7,832

7,832

10,897

10,897

10,897

10,897

10,897

10,897

10,897

Accrued compensation and benefits

72

58

55

60

62

61

305

313

309

309

298

309

302

335

340

934

1,483

623

1,046

900

738

652

1,224

1,047

879

712

550

379

1,114

853

1,579

377

1,086

915

785

632

1,712

Operating lease liabilities, current

67

90

90

90

90

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current liabilities

11

9

7

14

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current liabilities

-

-

-

-

12

-

8

12

10

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

3

-

-

-

24

24

41

34

82

93

109

97

Total current liabilities

1,145

1,387

907

937

902

511

862

1,287

758

1,132

1,010

999

883

665

2,167

1,953

3,344

2,551

2,586

1,813

1,200

850

2,383

1,739

1,618

1,801

9,655

9,218

9,694

9,999

13,800

12,421

12,938

13,272

13,085

12,818

14,071

Operating lease liabilities, non-current

-

-

23

45

68

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncurrent liabilities

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred program fee revenue - non-current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

27,412

29,370

31,329

33,287

32,690

35,415

38,139

40,863

43,587

46,312

51,760

Deferred tax liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

437

437

437

437

437

435

435

435

-

-

431

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

434

432

-

Total liabilities

1,145

1,387

930

982

970

511

862

1,287

758

1,132

1,010

999

883

665

2,167

1,953

3,344

2,551

2,586

1,813

1,200

850

2,383

1,739

1,618

1,801

37,504

39,025

41,460

43,723

46,927

48,271

51,512

54,570

57,106

59,562

66,262

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders' equity:
Preferred stock, $.001 par value; 10,000,000 shares authorized, none issued and outstanding

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $.001 par value; 120,000,000 shares authorized; 24,729,902 and 21,841,810 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

25

22

17

17

17

17

17

7

7

7

7

7

46

7

46

46

46

46

46

46

46

46

45

45

45

45

45

45

45

45

45

45

45

45

45

45

43

Additional paid-in capital

194,544

190,664

184,499

184,180

183,851

183,567

183,236

170,551

169,852

167,091

166,342

165,654

164,906

164,118

163,234

162,389

161,669

159,959

159,141

158,346

157,464

156,502

155,499

154,409

153,212

152,363

151,328

150,489

149,423

148,738

180,142

178,387

177,332

176,425

175,134

173,591

161,957

Accumulated other comprehensive income

-

-

-

-

-

-

-

-

-

-

0

0

0

0

1

-

-

0

1

1

1

1

1

-

1

1

1

1

1

4

2

43

96

128

121

394

525

Accumulated deficit

-169,737

-168,587

-167,071

-166,374

-165,315

-163,956

-163,279

-162,012

-159,559

-157,399

-154,982

-152,391

-148,231

-145,488

-142,966

-139,448

-136,433

-130,638

-126,121

-122,450

-119,076

-116,493

-114,337

-110,802

-107,557

-104,107

-137,122

-136,360

-136,059

-135,651

-133,857

-132,306

-132,175

-132,205

-131,814

-130,999

-129,592

Total stockholders' equity

24,832

22,099

17,445

17,823

18,553

19,628

19,974

8,546

10,300

9,699

11,367

13,270

16,721

18,637

20,315

22,987

25,282

29,367

33,067

35,943

38,435

40,056

41,208

43,652

45,701

48,302

14,252

14,175

13,410

13,136

46,332

46,169

45,298

44,393

43,486

43,031

32,933

Total liabilities and stockholders' equity

25,977

23,486

18,375

18,805

19,523

20,139

20,836

9,833

11,058

10,831

12,377

14,269

17,604

19,302

22,482

24,940

28,626

31,918

35,653

37,756

39,635

40,906

43,591

45,391

47,319

50,103

51,756

53,200

54,870

56,859

93,259

94,440

96,810

98,963

100,592

102,593

99,195